# A Study of the Neurological Effects of Adding Raltegravir to HAART Regimen in Patients With HIV

> **NCT01448486** · PHASE4 · TERMINATED · sponsor: **St Vincent's Hospital, Sydney** · enrollment: 6 (actual)

## Conditions studied

- Human Immunodeficiency Virus (HIV)
- HIV Associated Neurocognitive Disorders (HAND)

## Interventions

- **DRUG:** Raltegravir

## Key facts

- **NCT ID:** NCT01448486
- **Lead sponsor:** St Vincent's Hospital, Sydney
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-10
- **Primary completion:** 2013-10
- **Final completion:** 2013-10
- **Target enrollment:** 6 (ACTUAL)
- **Why stopped:** Funding withdrawn based on unacceptably slow recruitment rate.
- **Last updated:** 2016-06-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01448486

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01448486, "A Study of the Neurological Effects of Adding Raltegravir to HAART Regimen in Patients With HIV". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01448486. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*